Compositions for the treatment of peripheral neuropathies containing antidepressants and/or monoamine oxidase inhibitors and/or vitamin b12 and/or precursors or inducers of a neurotransmitter
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Examples
case # 1
Case #1
[0079] A 48 year old male, diagnosed non-insulin dependent diabetic when aged 28, showed symptoms of diabetic neuropathy which commenced approximately 8 years ago. The onset of neuropathy was thought to be due to poor control of diabetes. Neuropathic symptoms increased in severity over several years with development of severe diabetic neuropathy including diabetic amyotrophy, painful neuropathy with spasm, diabetic autonomic neuropathy and decreased sensation in the extremities, with numbing and loss of vibration sense. Electromyography confirmed the diagnosis of diabetic neuropathy.
[0080] Treatment with tricyclic antidepressants and carbemazepine was ineffective. An improvement in control of the patient's diabetes also did not significantly affect his severe symptoms.
[0081] A regime of 70 mg lofepramine and 500 mg LPA, each administered with informed consent twice daily, with weekly 1 mg vitamin B.sub.12 injections, significantly improved reported symptoms within 12 hours. A...
case # 2
Case #2
[0083] A 55 year old male with non-insulin dependent diabetes with very severe diabetic neuropathy, including diabetic amyotrophy and bedbound, resistant to current therapies, was commenced on vitamin B.sub.12 injections (1 mg at two-week intervals) and L-phenylalanine (as a metabolite of aspartame) 500 mg twice a day.
[0084] Benefit in amyotrophy was noted within 3 hours of commencement of treatment. The subsequent addition of lofepramine 70 mg twice daily produced a further improvement. Within 3 weeks his diabetic amyotrophy was considerably improved.
case # 3
Case #3
[0085] This case studied here is of the same 48 year old male with diabetic neuropathy as in case #1, but after the original observation in case #1. The patient was subsequently continued on the same vitamin B.sub.12 injections and phenylalanine (500 mg twice daily) only. He continued to benefit from his therapy whilst on these two drugs only, for approximately two months, and then required the recommencement of lofepramine to maintain good effect clinically.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com